Repertorial approach of treating tinea corporis using individualised homoeopathic medicines: Double-blind, randomized, placebo-controlled efficacy trial

D N De Homoeopathic Medical College Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1. Patients suffering from tinea corporis (B35.4) for 3 months or more, diagnosis confirmed through KOH mount test
•2. Age between 18 and 65 years
•3. Patients of either sex
•4. Literate patients; ability to read English and/or Bengali
•5. Providing written informed consent
•6. Patient using topical agents for tinea lesions will be included after a washout period of two weeks

•1. Cases with complication like lichenification and eczematisation
•2. Similar looking skin conditions; e.g., seborrheic dermatitis, pityriasis rosea and psoriasis
•3. Vulnerable population Ã¢â?¬â?? Unconscious, differently abled, terminally or critically ill patients, mentally incompetent people
•4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure
•5. Pregnant and puerperal women, lactating mothers
•6. Patient under tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence
•7. Self-reported immune-compromised state
•8. Already undergoing homoeopathic treatment for chronic disease within last 6 months

发起方